RAPT Therapeutics, Inc. (RAPT) Gains from Investment Securities (2020 - 2024)
RAPT Therapeutics' Gains from Investment Securities history spans 5 years, with the latest figure at $5.2 million for Q3 2024.
- For Q3 2024, Gains from Investment Securities changed N/A year-over-year to $5.2 million; the TTM value through Sep 2024 reached $5.2 million, up 252.99%, while the annual FY2024 figure was $100000.0, 97.56% down from the prior year.
- Gains from Investment Securities for Q3 2024 was $5.2 million at RAPT Therapeutics, up from $142623.0 in the prior quarter.
- Across five years, Gains from Investment Securities topped out at $6.6 million in Q1 2022 and bottomed at $27202.0 in Q1 2024.
- The 5-year median for Gains from Investment Securities is $726195.0 (2021), against an average of $1.8 million.
- The largest annual shift saw Gains from Investment Securities surged 1103.35% in 2021 before it plummeted 52.64% in 2023.
- A 5-year view of Gains from Investment Securities shows it stood at $2.4 million in 2020, then plummeted by 69.74% to $726195.0 in 2021, then soared by 103.53% to $1.5 million in 2022, then tumbled by 52.64% to $700000.0 in 2023, then soared by 645.3% to $5.2 million in 2024.
- Per Business Quant, the three most recent readings for RAPT's Gains from Investment Securities are $5.2 million (Q3 2024), $142623.0 (Q2 2024), and $27202.0 (Q1 2024).